'The newly acquired flow cytometry portfolio includes Amnis imaging flow cytometry products for cell-based analysis and the Guava portfolio of products, which leverage microcapillary technology and are also used for cell-based analysis. Homi Shamir, president and CEO of Luminex, said in a statement that the acquired Amnis and Guava products complement Luminex’s range of flow-based products'